SCHEMBL7181377

SCHEMBL7181377

O=C(c1c(C(F)(F)F)cccc1C(F)(F)F)P(=O)(C(=O)c1c(Cl)c(Cl)cc(Cl)c1Cl)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 1/20 0.40
GRM4 Q14833 1/20 0.36
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
KCNK3 O14649 1/20 0.35
KCNK9 Q9NPC2 1/20 0.35
PTGS2 P35354 1/20 0.35
RORC P51449 3/20 0.35
KDR P35968 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MRGPRX4 Q96LA9 1/20 0.34
PPARG P37231 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
CTSS P25774 1/20 0.34
CLCN2 P51788 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186743 0.91 TYK2 (0.39) TYK2GRM4ITGB1ITGA4KCNK3
SCHEMBL7186451 0.90 TYK2 (0.42) TYK2GRM4ITGB1ITGA4PTGS2
SCHEMBL7182186 0.88 TYK2 (0.48) TYK2ITGB1ITGA4PTGS2RORC
SCHEMBL7175972 0.87 TYK2 (0.40) TYK2GRM4ITGB1ITGA4KCNK3
SCHEMBL7187033 0.84 MAPT (0.40) TYK2KDM4ELMNAGAACTSS
SCHEMBL7180942 0.83 ALDH1A1 (0.39) TYK2KDM4E
SCHEMBL7182326 0.83 TYK2 (0.39) TYK2GRM4ITGB1ITGA4RORC
SCHEMBL7180976 0.82 TYK2 (0.43) TYK2ITGB1ITGA4PTGS2RORC
SCHEMBL7182180 0.80 FABP3 (0.36) TYK2ITGB1ITGA4LMNAGAA
SCHEMBL7175290 0.80 ALDH1A1 (0.39) TYK2KCNK3KCNK9RORCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 TYK2 1333/4885GRM4 1569/4885ITGB1 3321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.